Prospective and Retrospective Study of Outcomes for Patients with Malignant Melanoma

Cancer
Maki Yamamoto
[EXEMPT - REGISTRY TRIAL] Prospective and Retrospective Study of Outcomes for Patients with Malignant Melanoma
Melanoma skin

Study Description

Advances in the treatment of malignant melanoma are being developed in terms of medical information on

diagnosis, surgery, adjuvant therapy and post-treatment surveillance. The purpose of this protocol would be to

create a data repository by collecting key data elements to watch for patterns within melanoma to potentially

help future patients. By collecting this data, we intend to assess trends by watching for patterns of melanoma

inclusive of treatment, criteria for staging, time to recurrence, population, patients at risk for recurrence,

survival of patients, and time to death. The collection of this data will include a retrospective collection of

historical patients and a prospective collection from new patients within the melanoma UC Irvine Health clinics

Eligibility

You are eligible to participate in this study if you are at least 18 years old and have a confirmed diagnosis of

melanoma.

A female nurse attentively holds a tablet, ready to assist with patient care and medical information.

Interested in Participating in this Trial?

Thank you for your interest with our team.

One of our specialists will be in contact with you soon.